Bullisch
$189.42
Szenariopreis
$126.050
+1.210 (+0.96%)Zum Schluss
Leidos Holdings, Inc. is a holding company which operates through its wholly owned subsidiary, Leidos, Inc. (Leidos). The Company's segments include Intelligence & Digital, Health, Homeland and Defense. Its intelligence & digital segment integrates intelligence tradecraft, full-spectrum cyber capabilities, and technical solutions at scale for decision-making across large, distributed mission networks and classified environments. Its health segment offers information technology (IT) infrastructure modernization, software development, research and implementation, response to hazardous material incidents, mission software solutions and wellness exams. Its homeland segment serves five markets: air traffic, airports and borders, security equipment, commercial energy engineering and international. The Company's defense segment develops and produces advanced space, aerial, surface, and sub-surface manned and un-manned defense systems.
Leidos Holdings Inc is a good buy right now due to its current price of $124.85, which is significantly lower than the analyst price target of $141, suggesting a potential upside of approximately 13%. Additionally, the company's forward P/E ratio is 9.55, indicating it is undervalued compared to its earnings potential. The recent acquisition of ENTRUST for $2.4 billion is expected to enhance its market presence and revenue, contributing to future growth. However, a key risk is the recent downgrade by JPMorgan, which lowered its target from $160 to $142, reflecting concerns about future sales growth in the health unit.
JPMorgan
$142
2026-10-08
JPMorgan
2026-10-08
Kursziel
$142
Citi
$141
2026-10-07
Citi
2026-10-07
Kursziel
$141
TD Cowen
$130
2026-10-06
TD Cowen
2026-10-06
Kursziel
$130
Jefferies
$130
2026-10-06
Jefferies
2026-10-06
Kursziel
$130
Goldman Sachs
$132
2026-08-12
Goldman Sachs
2026-08-12
Kursziel
$132
Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

NASA Issues RFP for New Space Station as ISS Prepares for Retirement

Leidos Secures One-Year Extension of MOD Contract

Leidos Enhances U.S. Army Technology Integration

Blackstone Leads $1 Billion Financing for Analogic and Leidos Merger

Leidos Appoints New Investor Relations Executive
Leidos Holdings, Inc. is a holding company which operates through its wholly owned subsidiary, Leidos, Inc. (Leidos). The Company's segments include Intelligence & Digital, Health, Homeland and Defense. Its intelligence & digital segment integrates intelligence tradecraft, full-spectrum cyber capabilities, and technical solutions at scale for decision-making across large, distributed mission networks and classified environments. Its health segment offers information technology (IT) infrastructure modernization, software development, research and implementation, response to hazardous material incidents, mission software solutions and wellness exams. Its homeland segment serves five markets: air traffic, airports and borders, security equipment, commercial energy engineering and international. The Company's defense segment develops and produces advanced space, aerial, surface, and sub-surface manned and un-manned defense systems. It operates in the Technology sector (SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN industry).
Leidos Holdings Inc is a good buy right now due to its current price of $124.85, which is significantly lower than the analyst price target of $141, suggesting a potential upside of approximately 13%. Additionally, the company's forward P/E ratio is 9.55, indicating it is undervalued compared to its earnings potential. The recent acquisition of ENTRUST for $2.4 billion is expected to enhance its market presence and revenue, contributing to future growth. However, a key risk is the recent downgrade by JPMorgan, which lowered its target from $160 to $142, reflecting concerns about future sales growth in the health unit.
10 analysts cover LDOS: 10 rate it Buy, 0 Hold and 0 Sell. The average price target is 219.70.
Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.